
GC71355
Zharp2-1
Also known as N-(6-dimethylphosphoryl-7-methoxyquinolin-4-yl)-1,3-benzothiazol-5-amine
Zharp2-1 is an oral effective RIPK2 inhibitor, highly associated with inflammatory bowel disease (IBD)
ChemicalCAS2772600-18-5MW383.4FormulaC19H18N3O2PS
- CAS number
- 2772600-18-5
- Molecular weight
- 383.4
- Formula
- C19H18N3O2PS
- Solubility
- DMSO : 5 mg/mL (13·04 mM; ultrasonic and warming and heat to 60°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
- InChIKey
- SCBFIYRRWCWQAT-UHFFFAOYSA-N
- Catalogue number
- GC71355
- Brand
- GLPBIO
Computed properties PubChem CID 165123357 · XLogP 3.2 · TPSA 92.4 Ų · H-bond donors 1
- XLogP
- 3.2
- TPSA
- 92.4 Ų
- H-bond donors
- 1
- H-bond acceptors
- 6
- Rotatable bonds
- 4
- Heavy atoms
- 26
SMILES COC1=CC2=NC=CC(=C2C=C1P(=O)(C)C)NC3=CC4=C(C=C3)SC=N4
Computed descriptors from PubChem (CID 165123357), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il